Xiaodong Wang - Nov 15, 2022 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Director, Chair, Scientific Advisory Brd
Signature
/s/ Qing Nian, Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Nov 15, 2022
Transactions value $
-$417,541
Form type
4
Date filed
11/17/2022, 04:13 PM
Previous filing
Sep 8, 2022
Next filing
Nov 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE American Depositary Shares Sale -$418K -1.99K -100% $210.14 0 Nov 15, 2022 See Footnote F3, F5, F6, F7
holding BGNE Ordinary Shares 5.63M Nov 15, 2022 Direct
holding BGNE Ordinary Shares 1.13M Nov 15, 2022 See Footnote F1
holding BGNE Ordinary Shares 172K Nov 15, 2022 See Footnote F2
holding BGNE Ordinary Shares 4.16M Nov 15, 2022 See Footnote F3
holding BGNE Ordinary Shares 50 Nov 15, 2022 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
F2 These securities are held in a UTMA account for the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
F3 These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
F4 These securities are held by the spouse of the Reporting Person.
F5 Each American Depositary Share represents 13 Ordinary Shares.
F6 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2021, as most recently amended on June 15, 2022.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.01 to $210.49, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.